Antioxidant and Cholinesterase Inhibitory Activities of Aqueous Extract from Rainbow Trout
- DOI : 10.5657/FAS.2011.0089
- Author: Baek Jae-Min, Yoon Na Young, Kim Yeon-Kye, Lee Doo-Seog, Yoon Ho-Dong, Park Jeung-Sook
- Organization: Baek Jae-Min; Yoon Na Young; Kim Yeon-Kye; Lee Doo-Seog; Yoon Ho-Dong; Park Jeung-Sook
- Publish: Fisheries and aquatic sciences Volume 14, Issue2, p89~92, 30 June 2011
We investigated the antioxidant and cholinesterase inhibitory activities of the aqueous extract of rainbow trout
Oncorhynchus mykiss. The antioxidant activity of O. mykissaqueous extract was determined by in vitroperoxynitrite scavenging activity and reducing power assays. The aqueous extract of O. mykissshowed potent peroxynitrite radical scavenging activity (IC50=0.12±0.001 mg/mL) and reducing power (absorbance=0.47±0.001) at the concentration of 1 mg/mL. The in vitrocholinesterase inhibitory activity of O. mykissaqueous extract was examined using spectrophotometric analyses of acetyl- and butyrylcholinesterase. The aqueous extract of O.mykissshowed acetylcholinesterase inhibitory activity (IC50=1.61±0.13 mg/mL), but did not exhibit inhibitory activity against butyrylcholinesterase. These results suggest that O. mykisspossesses antioxidant and acetylcholinesterase inhibitory activities and provide scientific evidence for the health benefits of O. mykissaqueous extract.
Oncorhynchus mykiss , Rainbow trout , Antioxidant , Cholinesterase
The overproduction of free radical species causes oxidative stress that contributes to cellular aging and neuronal damage, and it is associated with chronic degenerative diseases, including Alzheimer’s disease(AD) (Sastre et al., 2000). AD, a progressive neurodegenerative disorder that is commonly seen in elderly individuals, is characterized by memory and cognitive ability loss, behavior disturbances, and personality changes (Bachman et al., 1992). The etiology of AD remains unclear; one of the most convincing theories is the cholinergic hypothesis,which implicates a deficiency in neurotransmitters,such as acetylcholine (ACh) and butyrylcholine(BCh) (Schneider, 2001). Efforts to prevent AD have focused on the activation of cholinergic functions through the inhibition of cholinesterase (ChE), which hydrolyzes the cholinergic neuromediators and reduces oxidative stress (Schneider, 2001).
Oncorhynchus mykissbelongs to the Salmonidae family of North American cold-water fish (Behnke,1992). O. mykissextracts have been reported to have potential health benefits, such as 3-hydroxy-3-methylglutaryl coenzyme A reductase expression reduction and antimutagenic effects (Oh et al., 2008,2009).
In the present study, the antioxidant and ChE inhibitory activities of
O. mykissaqueous extract were investigated in vitroby evaluating its ability to scavenge peroxynitrite anions (ONOO-), its reducing power, and its inhibitory activity against acetyl-(AChE) and butyrylcholinesterase (BChE). O. mykiss(average total length: 40-50 cm) were collected in May 2010 at Sangju City, Gyeongbuk,South Korea. Samples were prepared by removing the heads, fins, bones, and internal organs of the fish and obtaining extract in five times the volume of distilled water at 100°C for 3 h. After evaporating, the extract was freeze-dried.
Reducing power was evaluated by the method of Oyaizu (1986). Various concentrations of samples(2.5 mL) were mixed with 2.5 mL of 200 mM sodium phosphate buffer (pH 6.6) and 2.5-mL of 1%potassium ferricyanide. After incubation at 50°C for 20 min, 2.5 mL of 10% trichloroacetic acid (w/v) was added. The mixture was centrifuged at 2,000 g for 10 min, and 5 mL of the upper layer was mixed with deionized water and 1 mL of 0.1% ferric chloride.Absorbance was measured at 700-nm using a spectrophotometer (Powerwave XS; Bio-Tex, Inc.,Houston, TX, USA). L-ascorbic acid was used as a positive control.
ONOO- scavenging activity was measured by the method of Kooy et al. (1994) with minor modification.Each sample was mixed with rhodamine buffer (pH 7.4) and 5 mM dihydrorhodamine (DHR)123. After incubation for 5 min, the sample was treated with authentic ONOO-. The fluorescence intensity of the oxidized DHR 123 was measured with a microplate fluorescence reader (Wallac 1420;PerkinElmer, Waltham, MA, USA) at excitation and emission wavelengths of 485 nm and 530 nm,respectively. L-ascorbic acid was used as a positive control.
Inhibitory activity against ChE was measured using the spectrophotometric method developed by Ellman et al. (1961). The reaction mixture contained 140 mL of sodium phosphate buffer (pH 8.0), 20 μL of sample, and 20 μL of either AChE (0.36 U/mL) or BChE (0.36 U/mL). The solution was placed in a 96-well microplate, mixed, and incubated at room temperature for 15 min. After incubation, 10 μL of
Ellman’s reagent and 10 μL of ACh or BCh were added. The absorbance of all reactions was measured using a spectrophotometer (Powerwave XS; Bio-Tex,Inc.). Eserine was used as a positive control.
The proximate composition analysis was performed using the methods described by the Association of Official Analytical Chemists (1995).
Antioxidant properties are related to radical scavenging and reduction capacities. ONOO- is a strongly oxidizing and nitrating species that induces lipid peroxidation, thiol oxidation, and amino acid modification and causes DNA damage. ONOO- overproduction may cause several neurological diseases, such as AD and Parkinson’s disease(Squadrito and Pryor, 1998). Reduction is related to the donation of hydrogen atoms to ferric complexes and can disturb reactions between radicals (Singh and Rajini, 2004).
The antioxidant activity of
O. mykissaqueous extract was determined by evaluating ONOO- scavenging activity and reducing power. Table 1 and Fig. 1 show the results of these analyses. O. mykissaqueous extract exhibited potent ONOO- scavenging activity (IC50=0.12±0.001 mg/mL) and considerable reducing power that increased in a dose-dependent manner (absorbance=0.19±0.003, 0.26±0.0001,0.30±0.004, and 0.47±0.001 at concentrations of 0.1,0.2, 0.5, and 1 mg/mL, respectively). However, the ONOO- radical scavenging activity and reducing power of O. mykisswere lower than those of Lascorbic acid, which was used as a positive control.
According to Atif et al. (2006) and Oh et al. (2008), fish in the Salmonidae family contain small quantities
of several bioactive constituents, including phenolic ingredients and metallothioneins, which have shown positive correlations with antioxidant activity. The antioxidant activities of
O. mykissaqueous extract may be due to the presence of these constituents.
ChE inhibitors are recognized as the most promising therapeutic agents for AD, and have been shown to affect cognitive and behavioral symptoms in clinical studies (Giacobini, 2004). AChE inhibitors increase the endogenous levels of ACh and cholinergic neurotransmission. BChE inhibitors decrease the accumulation of neural plaques in senile brains.Thus, the achievement of a balance between AChE and BChE inhibitors may increase the efficacy of treatment (Yu et al., 1999).
The ChE inhibitory activity of
O. mykissaqueous extract was evaluated by AChE and BChE inhibitory activity assays. Table 1 presents the results of these analyses. O. mykissaqueous extract exhibited AChE inhibitory activity (IC50=1.61±0.13 mg/mL) but showed no BChE inhibitory activity. This selective AChE inhibitory activity may be due to the binding properties between the enzyme and substrate (Silman and Sussman, 2005). AChE is a substrate-specific enzyme that exists in nerve synapses and can degrade only ACh, whereas BChE is a nonspecific enzyme located in plasma and tissues (Silman and Sussman,2005). As with antioxidant activities, the AChE inhibitory activity of O. mykissaqueous extract was lower than that of eserine, which was used as a positive control.
The proximate composition of
O. mykissmeat is shown in Table 2. The moisture, crude protein, crude
lipid, and ash contents of
O. mykissmeat were determined to be 71.9±1.04, 20.8±0.78, 4.5±0.28,and 1.7±0.09% per 100 g of edible meat, respectively.The lipid components of O. mykissmeat contain bioactive constituents, including carotenoids and unsaturated fatty acids (Matsuno et al., 1980; Kim and Choi, 1993, Choi et al., 2010). Carotenoids, such as astaxanthin, zeaxanthin, canthaxanthin, diatoxanthin,and cryptoxanthin, and polyunsaturated fatty acids, including eicosapentaenoic acid and docosahexaenoic acid, are abundant in the integument and muscle of O. mykiss. These constituents have been reported to exhibit several beneficial bioactivities,including neuroprotective effects against neurotoxicity (Matsuno et al., 1980; Kim and Choi,1993; Lim et al., 2005).
O. mykissaqueous extract showed potent AChE inhibitory activity that may be related to its antioxidant properties. Further detailed investigations are necessary to isolate and identify the active constituents in the extract and to clarify the mechanism of their activity.
[Table 1.] The peroxynitrite (ONOO-) scavenging and cholinesterase inhibitory activity of the aqueous extract of Oncorhynchus mykiss
[Fig. 1.] The reducing power of the aqueous extract of Oncorhynchus mykiss.
[Table 2.] The proximate composition of Oncorhynchus mykiss meat